June 17, 2021
Beckers ASC Review
113 Followers on Owler
Progenity
Progenity is a California-based biotechnology company that develops and commercializes molecular testing products for hereditary cancer screening. Read more
Chairman & CEO
Harry Stylli
Missing a competitor? Contribute!
Natera is one of Progenity's top rivals. Natera was founded in San Carlos, California} in 2004. Like Progenity, Natera also competes in the Biotechnology space. Compared to Progenity, Natera generates $367.3M more revenue.
Weigh-in!
Help the Owler community know moreTrending News for Progenity and Progenity's Competitors
June 18, 2021
centralcharts
Natera Awarded Advanced Diagnostic Laboratory Test (ADLT) Status for its Signatera MRD Test From CMS
Natera Awarded Advanced Diagnostic Laboratory Test (ADLT) Status for its Signatera® MRD Test From CMS... See more »
June 18, 2021
Genomeweb
23andMe on the Nasdaq
23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition co... See more »
Progenity Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$82M
Progenity's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 183.6M. Over the last four quarters, Progenity's revenue has grown by 42%. Specifically, in Q1 2021's revenue was $24.5M; in Q4 2020, it was $14.3M; in Q3 2020, it was $25.9M; in Q2 2020, Progenity's revenue was $17.3M.
Progenity Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Medimetrics Personalized Drug Delivery B.V
Sep 2019
Source »undisclosed
Medimetrics designs, develops and manufactures ingestible medical devices.
These are all the companies that Progenity has acquired. Progenity's latest acquisition was Medimetrics Personalized Drug Delivery B.V in Sep 2019. Medimetrics designs, develops and manufactures ingestible medical devices.
Progenity Funding History
Since Progenity was founded in 2011, it has participated in 12 rounds of funding. In total Progenity has raised $517.2M. Progenity's last funding round was on Jun 2021 for a total of $40.0M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
Private Placement
Jun 2021
$40M
-
Post-IPO Equity
May 2021
--
-
Private Placement
Feb 2021
$25M
-
Post-IPO Debt
Dec 2020
$85.5M
-
IPO
Jun 2020
$100M
-
Since Progenity was founded in 2011, it has participated in 12 rounds of funding. In total Progenity has raised $517.2M. Progenity's last funding round was on Jun 2021 for a total of $40.0M
Progenity Investments
No recent investments found related to Progenity
These are all the companies that Progenity has invested in. Progenity's latest investment was Medimetrics Personalized Drug Delivery B.V in Sep 2019. Medimetrics designs, develops and manufactures ingestible medical devices.
Progenity News
June 10, 2021BioSpace
Progenity Announces $40 Million Private Placement
Progenity, Inc. today announced that it has entered into a definitive securities purchase agreement w... See more »
May 26, 2021Benzinga
Progenity's Targeted Delivery Of Adalimumab Shows Encouraging Action In Animal Models Induced With Colitis
Progenity Inc (NASDAQ: PROG) has announced results from a preclinical study evaluating the delivery o... See more »
May 24, 2021Markets Insider
Progenity Announces Poster Presentations at Digestive Disease Week 2021
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnolo... See more »
May 21, 2021Markets Insider
Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day - May 22nd
SAN DIEGO, May 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company w... See more »
May 13, 2021Genomeweb
Progenity Q1 Revenues Up 46 Percent
The company also said the number of tests performed in the quarter declined 3 percent from the fourth... See more »
May 11, 2021BioSpace
Progenity Receives Funding from Crohn's & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
Progenity , Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success ... See more »
Progenity Press Releases
May 26, 2021centralcharts
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Progenity , Inc. (Nasdaq: PROG), an innovative biotechnol... See more »
May 13, 2021centralcharts
Progenity Provides Corporate Update and Reports First Quarter 2021 Financial Results
Reports revenues of $24.5 million in the first quarter of 2021, up 72% from prior quarter Announced p... See more »
May 5, 2021GlobalNewswire
Progenity Provides Key Update Regarding its Preecludia Test for Preeclampsia
Pre-validation study demonstrates commercial laboratory systems readiness; data show strong performan... See more »
April 8, 2021StreetInsider
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) --...... See more »
March 3, 2021Cision Canada
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
/CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Silk Road"... See more »
February 11, 2021NewsFile
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
New York, New York--(Newsfile Corp. - February 11, 2021) - Pomerantz LLP is investigating claims on b... See more »
November 17, 2020GlobalNewswire
PROG) shares announced by Shareholders Foundation
SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsu... See more »
Progenity Videos
Social Media
Progenity Headquarters
Trending Companies
IN THE NEWS
Reddington Hospital | Rockwell Automation | Trigano | United Rentals | Ryanair | Eversource | POOLCORP | Ryan & Maniskas | Uber | Blackberry | MPC | Sherwin-Williams | Salesforce | PBC | Schlumberger | Cohbar | Microsoft | Korea Fund | Swedishhospital | KeyBank | DIRECTV | Airbnb | Apple | Marriott | Black & Veatch | Cohen & Steers | SBA | Sarasinandpartners | Coca-Cola | Hibbett | Mylan | Exact Sciences | Telford Homes | Cadence | Eagle Materials | Samsung | Albemarle | Simon | Carter's | EcoHealth Alliance | UnitedHealth Group | Baxter | Netflix | Assurant | Oncopeptides | Android | Actelion | 3M | Inovio | Marsh & McLennan
PEOPLE ALSO VIEWED
Wockhardt | Heat Biologics | Ipsen Pharma | Taconic Biosciences, Inc. | OriGene | United Therapeutics | Waters | Purolite | Elanco Animal Health Inc | EcoSynthetix | Epic Sciences | Genmab | Hyasynth Bio | Zoetis | Globus Medical | Nebo Agency | Zeta Global | Riskified | GameAnalytics | Corel | Cerevel Therapeutics | BioProcess Algae | Apitope | Kailosgenetics | Harvest One | FreeJobAlert | Reliance Digital | Heteroworld | FileMaker | RELIANCE TRENDS
Progenity Summary
ABOUT
Overview
Progenity is a California-based biotechnology company that develops and commercializes molecular testing products for hereditary cancer screening. Progenity was founded in 2011. Progenity's headquarters is located in San Diego, California, USA 92122. ...
CEO
Progenity's Chairman & CEO, Harry Stylli, currently has an approval rating of 99%. Progenity's primary competitors are Natera, Myriad & Invitae.Website
progenity.comFrequently Asked Questions about Progenity
When was Progenity founded?
Progenity was founded in 2011Who is Progenity's CEO?
Progenity's CEO is Harry StylliHow much revenue does Progenity generate?
Progenity generates $82M in revenueHow much funding does Progenity have?
Progenity has historically raised $517.2M in funding
Where is Progenity's headquarters?
Progenity's headquarters is in San Diego California, USAHow many employees does Progenity have?
Progenity has 674 employeesWhat sector does Progenity operate in?
Progenity is in BiotechnologyWho are Progenity's competitors?
Progenity's top competitors are Natera, Myriad, Invitae
